Catalent
CTLT
#1594
Rank
ยฃ8.43 B
Marketcap
ยฃ46.50
Share price
-0.35%
Change (1 day)
71.77%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Net assets

Net assets on the balance sheet as of September 2024 : ยฃ2.77 Billion

According to Catalent's latest financial reports the company has ยฃ2.77 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Catalent - Net assets on balance sheet (from 2013 to 2024)

Net assets by year

Year Net assets Change
2023-06-30$ยฃ3.65 B-7.13%
2022-06-30$ยฃ3.93 B27.48%
2021-06-30$ยฃ3.08 B8.41%
2020-06-30$ยฃ2.84 B58.01%
2019-06-30$ยฃ1.80 B119.09%
2018-06-30$ยฃ0.82 B47.95%
2017-06-30$ยฃ0.55 B17.75%
2016-06-30$ยฃ0.47 B17.18%
2015-06-30$ยฃ0.40 B-284.64%
2014-06-30$-ยฃ0.22 Billion-19.07%
2013-06-30$-ยฃ0.27 Billion20.66%
2012-06-30$-ยฃ0.23 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
ยฃ0.79 B-71.57%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.13 Billion-104.63%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.27 B 17.76%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
ยฃ56.38 M-97.97%๐Ÿ‡บ๐Ÿ‡ธ USA